{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:04:12Z","timestamp":1778198652566,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009898","name":"Beckett-Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010727","name":"Axel Muusfeldts Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejca.2020.10.038","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T18:55:13Z","timestamp":1608231313000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6042-779X","authenticated-orcid":false,"given":"Louise S.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette K.","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula G.","family":"Falkmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurids \u00d8.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"B\u00f8gsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi S.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stig E.","family":"Bojesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny V.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4948-6799","authenticated-orcid":false,"given":"Astrid Z.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9256-2240","authenticated-orcid":false,"given":"Carsten P.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane P.","family":"Hasselby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2509-2231","authenticated-orcid":false,"given":"Niels","family":"Holl\u00e4nder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svend E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahimeh","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1088-7242","authenticated-orcid":false,"given":"Jon K.","family":"Bjerregaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia S.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2020.10.038_bib1","first-page":"1","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejca.2020.10.038_bib2","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2020.10.038_bib3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2020.10.038_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2020.10.038_bib5","doi-asserted-by":"crossref","first-page":"29820","DOI":"10.18632\/oncotarget.25661","article-title":"Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer","volume":"9","author":"Vainer","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2020.10.038_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1158\/1055-9965.EPI-19-0672","article-title":"Prognostic value of combined detection of serum interleukin-6, YKL-40, and C-reactive protein in patients with unresectable pancreatic cancer","volume":"29","author":"Chen","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2020.10.038_bib7","doi-asserted-by":"crossref","first-page":"107394","DOI":"10.1016\/j.pharmthera.2019.107394","article-title":"Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases","volume":"203","author":"Yeo","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ejca.2020.10.038_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12935-019-0983-y","article-title":"Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies","volume":"19","author":"Bian","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ejca.2020.10.038_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1079\/BJN20051544","article-title":"Putting cardiovascular disease and vitamin D insufficiency into perspective","volume":"94","author":"Zittermann","year":"2005","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ejca.2020.10.038_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/1043-4666(92)90012-G","article-title":"1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level","volume":"4","author":"M\u00fcller","year":"1992","journal-title":"Cytokine"},{"key":"10.1016\/j.ejca.2020.10.038_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/eje.0.1450351","article-title":"1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes","volume":"145","author":"Canning","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejca.2020.10.038_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000069149","article-title":"Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number","volume":"3","author":"Albrechtsson","year":"2003","journal-title":"Pancreatology"},{"key":"10.1016\/j.ejca.2020.10.038_bib13","first-page":"1875","article-title":"Anti-growth effect of 1,25-dihydroxyvitamin D3-3-bromoacetate alone or in combination with 5-amino-imidazole-4-carboxamide-1-beta-4-ribofuranoside in pancreatic cancer cells","volume":"30","author":"Persons","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2020.10.038_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4161\/cbt.7.3.5418","article-title":"19-nor-1\u03b1,25-Dihydroxyvitamin D 2 (Paricalcitol) inhibits the proliferation of human pancreatic cancer cells in\u00a0vitro and in\u00a0vivo","volume":"7","author":"Schwartz","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ejca.2020.10.038_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12937-016-0135-3","article-title":"Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer","volume":"15","author":"McGovern","year":"2016","journal-title":"Nutr J"},{"key":"10.1016\/j.ejca.2020.10.038_bib16","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1200\/JCO.2015.66.3005","article-title":"Prediagnostic plasma 25-hydroxyvitamin D and pancreatic cancer survival","volume":"34","author":"Yuan","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2020.10.038_bib17","unstructured":"BIOmarkers in patients with Pancreatic Cancer (BIOPAC). https:\/\/www.herlevhospital.dk\/BIOPAC\/Sider\/default.aspx Accesed on 18 June 2020."},{"key":"10.1016\/j.ejca.2020.10.038_bib18","article-title":"Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer","volume":"29","author":"Bagni","year":"2020","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.ejca.2020.10.038_bib19","series-title":"National clinical guidelines","year":"2015"},{"key":"10.1016\/j.ejca.2020.10.038_bib20","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejca.2020.10.038_bib21","series-title":"TNM classification of malignant tumours","author":"Sobin","year":"2009"},{"key":"10.1016\/j.ejca.2020.10.038_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.06.030","article-title":"Vitamin D and pancreatic cancer","volume":"368","author":"Barreto","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2020.10.038_bib23","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.clinbiochem.2004.06.006","article-title":"Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON\u00ae automated analyzer","volume":"37","author":"Ersfeld","year":"2004","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ejca.2020.10.038_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.10.038_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jsbmb.2004.03.040","article-title":"Which circulating level of 25-hydroxyvitamin D is appropriate?","volume":"89\u201390","author":"Lips","year":"2004","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ejca.2020.10.038_bib26","series-title":"Vitamin D deficiency","year":"2010"},{"key":"10.1016\/j.ejca.2020.10.038_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13547500701615017","article-title":"Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis","volume":"13","author":"Knudsen","year":"2008","journal-title":"Biomarkers"},{"key":"10.1016\/j.ejca.2020.10.038_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cca.2011.01.022","article-title":"Plasma YKL-40 levels in healthy subjects from the general population","volume":"412","author":"Bojesen","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejca.2020.10.038_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejca.2020.10.038_bib30","doi-asserted-by":"crossref","first-page":"1678S","DOI":"10.1093\/ajcn\/80.6.1678S","article-title":"Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease","volume":"80","author":"Holick","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ejca.2020.10.038_bib31","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1210\/jc.2013-3507","article-title":"Vitamin D deficiency is associated with inflammation in older Irish adults","volume":"99","author":"Laird","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejca.2020.10.038_bib32","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1017\/jns.2015.33","article-title":"Vitamin D-rich marine Inuit diet and markers of inflammation \u2013 a population-based survey in Greenland","volume":"4","author":"Sch\u00e6bel","year":"2015","journal-title":"J Nutr Sci"},{"key":"10.1016\/j.ejca.2020.10.038_bib33","doi-asserted-by":"crossref","first-page":"64395","DOI":"10.18632\/oncotarget.18888","article-title":"Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2020.10.038_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.canlet.2014.08.019","article-title":"The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial\u2013mesenchymal transition in pancreatic cancer cells","volume":"354","author":"Chiang","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2020.10.038_bib35","unstructured":"High-dose Vitamin D3 in Pancreas Cancer (VITdCUT) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03472833?te Accesed on 18 June 2020."},{"key":"10.1016\/j.ejca.2020.10.038_bib36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.bjc.6600162","article-title":"A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer","volume":"86","author":"Evans","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2020.10.038_bib37","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.10.038_bib38","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920313277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804920313277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:30:03Z","timestamp":1760733003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804920313277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":38,"alternative-id":["S0959804920313277"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.10.038","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-treatment serum vitamin D deficiency is associated with increased inflammatory biomarkers and short overall survival in patients with pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}